
We’ve seen plagiarizers plagiarizing plagiarizers, but here’s what seems to be a first: A journal has retracted an article that duplicated text…from a paper that had been retracted for containing dubious data.
The Journal of Applied Pharmaceutical Science published the recycled paper, titled “Development and in vitro-in vivo characterization of chronomodulated multi-particulate drug delivery system of terbutaline sulphate for treatment of nocturnal asthma by box–Behnken statistical design.” The authors were from several institutions in India.
As the retraction notice explains: Continue reading Authors try to duplicate bad data, fail miserably
As we’re fond of repeating, sunlight is the best disinfectant. Which doesn’t jibe with the findings in an eye-catching 2018 paper that found people were less fearful of catching a contagious illness if they were in a dark room or were wearing sunglasses. 



The FDA has walked away from a 2010 rule that would have forced drug makers to disclose fabricated data to regulators. 

